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Of the concepts used to improve the efficiency of organic syntheses, two have been especially effective: atom economy 1 (the use of routes in which most of the atoms present in the reactants also end up in the product) and chemoselectivity 2 (the use of reactions that take place only at desired positions in a molecule). Synthesis of complex natural products is the most demanding arena in which to explore such principles. The bryostatin family of compounds are especially interesting targets, because they combine structural complexity with promising biological activity [3] [4] [5] [6] [7] . Furthermore, synthetic routes to some bryostatins have already been reported [9] [10] [11] [12] , providing a benchmark against which new syntheses can be measured. Here we report a concise total synthesis of bryostatin 16 (1), a parent structure from which almost all other bryostatins could in principle be accessed. Application of atomeconomical and chemoselective reactions currently under development provides ready access to polyhydropyran motifs in the molecule, which are common structural features of many other natural products. The most notable transformations are two transition-metal-catalysed reactions. The first is a palladium-catalysed reaction of two different alkynes to form a large ring. The product of this step is then converted into a dihydropyran (the 'C ring' of bryostatins) in the second key reaction, which is catalysed by a gold compound. Analogues of bryostatin that do not exist in nature could be readily made by following this route, which might allow the biological activity of bryostatins to be fine-tuned.
The bryostatins 1-20 ( Fig. 1 ), which were originally isolated from the marine bryozoan Bugula neritina, are a class of structurally complex macrolactone natural products that exhibit exceptional biological activity, most notable their anticancer activity in vivo 3 . Clinical application of bryostatin in combinatizon with other chemotherapeutic agents has shown significant potential in treating some cancers with high potency 4, 5 . Furthermore, recent studies have revealed that bryostatin significantly affects both cognition and memory enhancement in animals, which suggests its potential use in the treatment of Alzheimer's disease, depression and other cognitive impairments 6 . Although bryostatins' activities could be attributed to their strong affinity for protein kinase C isozymes 7 , their actual mode of action is still an important research subject. However, their clinical advancement is hampered by the limited availability of bryostatins from isolation, due to low yield (,1.6 3 10 24 %; 18 g of bryostatin 1, one of the most abundant members, from 14 t of animals on an industrial scale 8 ) and there being a non-renewable supply. Therefore, efficient total syntheses of these natural products [9] [10] [11] [12] and their analogues [13] [14] [15] [16] remain in high demand.
The structures of bryostatins pose significant challenges to their synthesis; the structures include three heavily substituted tetrahydropyran rings, two acid/base-sensitive exo-cyclic unsaturated esters and one congested C16-C17 trans-alkene, as well as numerous oxygen-containing functionalities on a 26-membered lactone. As an example, the challenge posed by the C16-C17 double bond led to failure in routes relying on its formation by metathesis reactions 17 , even in the case of a relay metathesis strategy 16 . Despite their biological, clinical and structural significance, until now only three of the 20 bryostatins have been accessed by total synthesis (bryostatin 7 (ref. With a goal of streamlining the strategy to these complicated targets to enable better access, we choose bryostatin 16 (1) 18 as the specific synthetic target, for three reasons. First, bryostatin 16 could act as a pivotal parent structure allowing access to all other bryostatins (except bryostatins 3, 19 and 20; see Fig. 1 ) by elaboration of the electron-rich and relatively reactive C19-C20 alkene 10, 16 (for a biosynthetic approach, see ref. 19 ). Second, the dihydropyran entity of Bryostatin 17 (C21-C34 isomer)
Oxidation of C19-C20 alkene Hydration of C19-C20 alkene the C ring in 1 offers an ideal forum for us to explore a palladiumcatalysed alkyne-alkyne coupling as a macrocyclization method 20 for complex natural product synthesis. Third, new analogues, which are not easily available from other syntheses, might be readily obtained simply by variations in this natural product's synthesis.
From the viewpoint of retrosynthetic analysis, the acid and/or base sensitivity of the C ring of bryostatins 10 leads us to a strategy of constructing the C ring of bryostatin 16 at the very end of the synthesis. The benefits of this also include flexible late variations for access to other bryostatins or analogues, as well as minimization of functional group transformation and protecting group usage. Whereas all previous total syntheses have relied on assembling the macrocycle by performing a difficult Julia olefination followed by a lactonization, we predict that the use of a palladium-catalysed chemoselective alkyne-alkyne coupling followed by a metal-catalysed 6-endo-dig cyclization will efficiently produce both the macrocycle and the C ring of 1 (Fig. 2) . Esterification between fragments 4 and 5 will give the requisite diyne precursor. Fragment 5 can be synthesized from vinyl silane 6. The 4-methylene-2,6-cis-tetrahydropyran moiety in intermediate 6 provides us with an opportunity to examine our ruthenium-catalysed alkene-alkyne coupling/Michael addition methodology 21 between two complex fragments (7 and 8), with the aim of addressing some questions in chemoselectivity. Given the difficulty of forming the sterically hindered C16-C17 alkene in the late stage (either by Julia olefination 10 or ring-closing metathesis 16, 17 ), alkyne 8 is specifically designed to install this trans-alkene in an early stage.
Alkene 7 has previously been synthesized in 16 steps from (R)-pantolactone 16 . This synthesis can be shortened (Fig. 3) , however, by starting from aldehyde 2. Asymmetric Brown allylation 22 , followed by protection of the resulting alcohol with p-methoxybenzyl (PMB) group and oxidative alkene-cleavage, quickly afforded aldehyde 10 as the same intermediate in our previous synthesis. With this modification, alkene 7 is now available in 11 steps from aldehyde 2. Enantioselective synthesis of alkyne 8 is achieved in four steps from aldehyde 2 (Fig. 3) . Homologation, followed by indium-mediated propargylation 23 efficiently gives racemic 8 in good yield. (R)-8 is then obtained in 90% yield and 90% enantiomeric excess through careful Dess-Martin oxidation 24 followed by Corey-Bakshi-Shibata reduction 25 of the corresponding ketone. With both alkene 7 and alkyne 8 in hand, we proceed with the ruthenium-catalysed tandem alkene-alkyne coupling/Michael addition to generate cis-tetrahydropyran 6. The chemoselectivity is demonstrated by the high compatibility of a b,c-unsaturated ketone, a six-membered lactone, an unprotected allylic alcohol, a PMB ether and two different silyl ethers in this reaction. We find dichloromethane (DCM) to be the optimal solvent for this reaction, whereas acetone or a dichloromethane-N,N-dimethylformamide mixed solvent gives either lower conversion or more decomposition. Notably, only 1.2 equiv. of alkene 7 is required in this coupling reaction (Fig. 4a) . Although the yield is moderate, presumably because additional alkene functionality in the alkyne fragment could lower the turnover number of the ruthenium catalyst, this result has been proved to be highly reproducible and both starting materials could be recovered, guaranteeing enough materials for the rest of the synthesis. Subsequent bromination of the exo-cyclic vinyl silane followed by a camphorsulfonic-acid-catalysed transesterification/methyl ketalization/desilylation all in one event cleanly gives the desired alcohol 13 containing both the A-ring and B-ring substructures in over 90% yield. The vinyl bromide functionality may serve as a convenient handle for the syntheses of bryostatin analogues through the use of metal-catalysed coupling reactions. We next use palladium-catalysed carbonylation to install the exo-cyclic conjugated methyl ester. DessMartin oxidation of the primary alcohol 14 followed by OhiraBestmann alkynylation 26 and desilylation provides donor alkyne 15 for the alkyne-alkyne coupling. We overcome the challenge of chemoselective hydrolysis of the b-hydroxy methyl ester in the presence of the a,b-unsaturated methyl ester by using of trimethyltin hydroxide 27 in 1,2-dichloroethane; we hypothesize that, owing to the Lewis acidity of trimethyltin hydroxide, the adjacent alcohol could act as a directing group in the saponification reaction. Subsequent protection of the alcohol with triethylsilyl group completes the synthesis of acid fragment 5. Alcohol fragment 4 is synthesized in three steps from the known 16 homo-propargyl alcohol 17 (Fig. 4b) . Esterification between acid 5 and alcohol 4 proceeds in 92% yield using Yamaguchi's conditions 28 (Fig. 5) . Oxidative removal of the two PMB protecting groups using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone gives the macrocyclization precursor 3. After extensive experimentation, we find that treatment of 3 with 12 mol% Pd(OAc) 2 and 15 mol% tris(2,6-dimethoxyphenyl)phosphine in toluene at room temperature (20-25 uC) successfully provides the desired macrocycle 20 with reasonably good yield (56%), whereas the use of tetrahydrofuran or benzene as solvent, or a lower ligand/ palladium ratio proves less efficient. As for other macrocyclizations, low concentration (0.002 M) proves to be critical; otherwise, formation of the dimeric by-products could be observed. This example of using palladium-catalysed alkyne-alkyne coupling as a macrocyclization method in a complex natural product synthesis illustrates a new way of constructing a macrocycle using carbon-carbon bond formation. Mechanistically, the palladium catalyst chemoselectively inserts into the carbon-hydrogen bond of the terminal alkyne; this sets the stage for the chemo-and regioselective intramolecular carbometalation of the disubstituted alkyne, which, after reductive elimination of the formed vinyl palladium hydride, creates the macrocycle efficiently in spite of the complexity of the substrate.
The remaining challenge is to conduct a 6-endo-dig cyclization to form the C ring of bryostatin. Owing to the modest selectivity in the palladium-catalysed reaction (5-exo versus 6-endo) and the difficulty in separating these isomers 16 , we seek a more regioselective catalyst. After extensive screening of a number of metals, we settle upon a cationic gold complex, [Au(PPh 3 )]SbF 6 , as the catalyst (for a cationic gold-catalysed 5-exo cyclization, see ref. 29 ). DCM-CH 3 CN (10:1), as a mixed solvent in the presence of NaHCO 3 (10 equiv.) as a buffer, gives the acid-sensitive 6-endo product in 73% isolated yield. Subsequent pivalation of the hindered secondary alcohol under forcing conditions (Piv 2 O, 50 equiv.; N,N-4-dimethylaminopyridine, 80 equiv.; 50 uC) 30 does afford the pivalate ester 21 in 62% yield. The following global deprotection proves to be nontrivial: hydrogen fluoride-pyridine, aqueous hydrofluoric acid, aqueous acetic acid, pyridinium p-toluenesulfonate and so on give either decomposition or isomerization. We eventually find an extreme acid sensitivity of this natural product. By contrast with these acid conditions, treatment of 21 with 5 equiv. of tetra-n-butylammonium fluoride and direct purification by reverse-phase high-performance liquid chromatography successfully provides bryostatin 16 (1) 18 . In conclusion, we have developed a highly concise strategy (26-step longest linear sequence, 39 total steps from aldehyde 2) for the asymmetric total synthesis of bryostatin 16. The synthetic efficiency can be attributed to a tandem ruthenium-catalysed alkene-alkyne coupling/ Michael addition to form the B ring, an acid-catalysed one-pot cascade to form the A ring, a directed chemoselective hydrolysis, a palladiumcatalysed alkyne-alkyne coupling as a macrocyclization reaction and a gold-catalysed 6-endo-dig cyclization to form the C ring of bryostatin 16 . We believe that all these atom-economical and chemoselective approaches could have implications beyond this work. The conciseness of this synthesis readily allows access to significant quantities of this key bryostatin, and implementation of this strategy towards the synthesis of various bryostatins and their analogues, and performance of the related biological experiments, is being undertaken.
